GlassScriptPhysician profile
George S Lin
NPI 1518927474
$8,458.53
in general payments reported to CMS, 2019-2025
43 companies · $1,969 in 2025
The $1,969 reported for 2025 was more than what 76% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,045 · 2020: $175 · 2021: $574 · 2022: $1,426 · 2023: $1,421 · 2024: $1,850 · 2025: $1,969.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,977 · Education: $262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,977.42 |
| Education | $262.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,465.60 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,066.47 | 2019-2025 | Breztri, Tezspire, Fasenra |
| Genzyme Corporation | $739.31 | 2019-2025 | |
| Insmed, INC. | $555.43 | 2019-2025 | Arikayce, Brinsupri |
| Philips North America LLC | $427.04 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $392.30 | 2019-2024 | Ofev, Spiriva Respimat |
| Mylan Specialty L.P. | $333.33 | 2019-2024 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $259.87 | 2021-2025 | Dupixent |
| Electromed, INC. | $227.44 | 2019-2025 | Smartvest |
| Actelion Pharmaceuticals US, INC. | $224.46 | 2023-2025 | Opsumit |
| Harmony Biosciences LLC | $214.56 | 2023-2025 | Wakix |
| Sanofi-Aventis U.S. LLC | $189.98 | 2024-2025 | |
| Medtronic, INC. | $189.91 | 2022-2023 | Appose Ulc |
| Baxter Healthcare | $180.42 | 2022-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System |
| Grifols USA, LLC | $178.33 | 2019-2025 | Prolastin-C Liquid, Xembify |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $175.96 | 2019 | |
| Asensus Surgical, INC. | $164.52 | 2022-2024 | Senhance |
| United Therapeutics Corporation | $157.28 | 2022-2025 | Tyvaso, Tyvaso, Orenitram |
| Viatris Specialty LLC | $128.49 | 2025 | Yupelri |
| Avadel Cns Pharmaceuticals, LLC | $124.10 | 2023-2025 | Lumryz |
| Azurity Pharmaceuticals, INC. | $99.95 | 2023-2025 | Horizant, Horizant |
| Verona Pharma, INC. | $97.23 | 2025 | Ohtuvayre |
| Takeda Pharmaceuticals U.S.A., INC. | $91.19 | 2022-2025 | Glassia, Aralast |
| Merck Sharp & Dohme LLC | $88.41 | 2019-2023 | |
| Teva Pharmaceuticals USA, INC. | $76.39 | 2019-2022 | |
| Covis Pharma Gmbh | $74.96 | 2022-2023 | |
| Amgen INC. | $63.01 | 2023-2025 | Tezspire, Tavneos |
| Jazz Pharmaceuticals INC. | $58.96 | 2020-2025 | |
| Circassia INC. | $56.44 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $41.89 | 2019 | |
| Pfizer INC. | $40.12 | 2022-2024 | |
| Inspire Medical Systems, INC. | $36.10 | 2023-2024 | Inspire |
| Lilly USA, LLC | $33.88 | 2025 | Zepbound |
| Arbor Pharmaceuticals, INC. | $31.63 | 2021 | |
| Optinose US, INC. | $30.93 | 2025 | |
| Idorsia Pharmaceuticals US INC | $28.85 | 2022-2023 | Quviviq |
| Pulmonx Corporation | $18.66 | 2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Inogen, INC. | $18.33 | 2025 | |
| Tactile Systems Technology INC | $18.06 | 2021 | |
| Axsome Therapeutics, INC. | $16.10 | 2025 | Sunosi |
| Shockwave Medical, INC | $14.78 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.38 | 2023 | |
| Resmed Corp | $13.48 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.